Completed PHASE1 INTERVENTIONAL 2-arm NCT01034774

Phase 1 Study to Determine Safety, Blood PK and Lung Penetration

A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, Plasma Pharmacokinetics and Lung Penetration of Intravenous (IV) ACHN-490 in Healthy Subjects

Sponsor: Achaogen, Inc.

Conditions Healthy Volunteers

Interventions ACHN-490 Injection Placebo (normal saline)

Updated 6 times since 2017 Last updated: Feb 24, 2012 Started: Jan 31, 2010 Primary completion: Jun 30, 2010 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01034774, this PHASE1 trial focuses on Healthy Volunteers and remains completed. Sponsored by Achaogen, Inc., it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Achaogen, Inc.

Data source: Achaogen, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.